ZA9710435B - Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation. - Google Patents

Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation.

Info

Publication number
ZA9710435B
ZA9710435B ZA9710435A ZA9710435A ZA9710435B ZA 9710435 B ZA9710435 B ZA 9710435B ZA 9710435 A ZA9710435 A ZA 9710435A ZA 9710435 A ZA9710435 A ZA 9710435A ZA 9710435 B ZA9710435 B ZA 9710435B
Authority
ZA
South Africa
Prior art keywords
dalfopristine
quinupristine
preparation
pharmaceutical compositions
compositions based
Prior art date
Application number
ZA9710435A
Other languages
English (en)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA9710435B publication Critical patent/ZA9710435B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9710435A 1996-11-19 1997-11-19 Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation. ZA9710435B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (1)

Publication Number Publication Date
ZA9710435B true ZA9710435B (en) 1998-06-10

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710435A ZA9710435B (en) 1996-11-19 1997-11-19 Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation.

Country Status (45)

Country Link
US (1) US5994338A (xx)
EP (1) EP0949923B1 (xx)
JP (1) JP4278115B2 (xx)
KR (1) KR100530836B1 (xx)
CN (1) CN1146417C (xx)
AP (1) AP998A (xx)
AR (1) AR008695A1 (xx)
AT (1) ATE223217T1 (xx)
AU (1) AU740291B2 (xx)
BG (1) BG63621B1 (xx)
BR (1) BR9713087A (xx)
CA (1) CA2271095C (xx)
CO (1) CO4910113A1 (xx)
CZ (1) CZ299913B6 (xx)
DE (1) DE69715247T2 (xx)
DK (1) DK0949923T3 (xx)
DZ (1) DZ2349A1 (xx)
EA (1) EA002025B1 (xx)
EE (1) EE03668B1 (xx)
ES (1) ES2179375T3 (xx)
FR (1) FR2755857B1 (xx)
HK (1) HK1022832A1 (xx)
HR (1) HRP970615B1 (xx)
HU (1) HUP9904327A3 (xx)
IL (2) IL129607A0 (xx)
IN (1) IN187038B (xx)
JO (1) JO1992B1 (xx)
MA (1) MA26448A1 (xx)
MY (1) MY123805A (xx)
NO (1) NO992399L (xx)
NZ (1) NZ334949A (xx)
OA (1) OA11047A (xx)
PE (1) PE13999A1 (xx)
PL (1) PL190164B1 (xx)
PT (1) PT949923E (xx)
RS (1) RS49608B (xx)
SA (1) SA97180645B1 (xx)
SK (1) SK284311B6 (xx)
TN (1) TNSN97184A1 (xx)
TR (1) TR199901096T2 (xx)
TW (1) TW474816B (xx)
UA (1) UA59376C2 (xx)
UY (1) UY24780A1 (xx)
WO (1) WO1998022107A1 (xx)
ZA (1) ZA9710435B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
PT1115417E (pt) * 1998-09-25 2006-07-31 Cubist Pharm Inc Utilizacao da daptomicina
ES2433678T3 (es) * 1999-03-03 2013-12-12 Eli Lilly & Company Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HRP970615A2 (en) 1998-08-31
HUP9904327A2 (hu) 2000-06-28
BG103412A (en) 2000-06-30
EA199900479A1 (ru) 2000-02-28
TW474816B (en) 2002-02-01
HUP9904327A3 (en) 2002-03-28
ES2179375T3 (es) 2003-01-16
WO1998022107A1 (fr) 1998-05-28
IN187038B (xx) 2001-12-29
CA2271095A1 (fr) 1998-05-28
DE69715247D1 (de) 2002-10-10
AU5125698A (en) 1998-06-10
DK0949923T3 (da) 2002-12-23
SK284311B6 (sk) 2005-01-03
CN1146417C (zh) 2004-04-21
EP0949923B1 (fr) 2002-09-04
JO1992B1 (en) 1999-05-15
DZ2349A1 (fr) 2002-12-28
RS49608B (sr) 2007-06-04
NZ334949A (en) 2000-12-22
BG63621B1 (bg) 2002-07-31
CN1233959A (zh) 1999-11-03
TNSN97184A1 (fr) 2005-03-15
PL190164B1 (pl) 2005-11-30
PE13999A1 (es) 1999-05-05
HRP970615B1 (en) 2002-12-31
JP4278115B2 (ja) 2009-06-10
NO992399D0 (no) 1999-05-19
AP998A (en) 2001-08-09
UY24780A1 (es) 2001-08-27
HK1022832A1 (en) 2000-08-25
CZ174899A3 (cs) 1999-08-11
EE9900127A (et) 1999-12-15
AU740291B2 (en) 2001-11-01
TR199901096T2 (xx) 1999-07-21
KR100530836B1 (ko) 2005-11-23
KR20000053343A (ko) 2000-08-25
SK66099A3 (en) 2000-01-18
PT949923E (pt) 2003-01-31
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
MY123805A (en) 2006-06-30
EE03668B1 (et) 2002-04-15
OA11047A (fr) 2003-03-07
US5994338A (en) 1999-11-30
ATE223217T1 (de) 2002-09-15
IL129607A0 (en) 2000-02-29
CA2271095C (fr) 2004-08-03
IL129607A (en) 2006-08-20
JP2001504475A (ja) 2001-04-03
EA002025B1 (ru) 2001-12-24
AR008695A1 (es) 2000-02-09
DE69715247T2 (de) 2003-04-30
YU22499A (sh) 2002-03-18
EP0949923A1 (fr) 1999-10-20
BR9713087A (pt) 2000-03-28
MA26448A1 (fr) 2004-12-20
FR2755857B1 (fr) 1998-12-24
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
NO992399L (no) 1999-05-19
CZ299913B6 (cs) 2008-12-29

Similar Documents

Publication Publication Date Title
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
EG24118A (en) Pharmaceutical compositions
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
GB9616672D0 (en) Pharmaceutical compositions
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
GB9610359D0 (en) Pharmaceutical compositions
ZA971746B (en) Taxoids, their preparation and pharmaceutical compositions containing them.
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
HK1040165A1 (en) Nutritional and pharmaceutical compositions
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA9710435B (en) Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation.
GB9606429D0 (en) Pharmaceutical compositions
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
GB9613457D0 (en) Pharmaceutical compositions
ZA9711047B (en) Formulation and use.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
SI0949923T1 (en) Stabilised pharmaceutical compositions, based on quinupristine and dalfopristine, and their preparation
ZA974422B (en) Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.